RETREG1 and hepatocellular carcinoma: To explore whether FAM134B promotes HCC progression through DDX3X expression, we established two cell lines: one with overexpression of FAM134B and reduced DDX3X expression (Hep3B), and another with reduced FAM134B and overexpression of DDX3X (MHCC97-H).